Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW (SMARTFLOW) Study

NCT07676097 is registered in ClinicalTrials.gov with AngioInsight as lead sponsor.

NCT NCT07676097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07676097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW (SMARTFLOW) Study
Lead sponsor
AngioInsight
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 31, 2027
Enrollment
620 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute or chronic coronary artery disease, non-obstructive coronary disease